Endometrial Carcinoma — Trials

Endometrial Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

325 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 109
Recruiting: 52
Ph III recruiting: 4
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 26.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (31)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05316467	Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma	terminated	Phase 2 / Phase 3	8	Xiaojun ChenOTHER	1	Jun 4, 2026	clinicaltrials
NCT04159155	A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer(CAN-STAMP)	terminated	Phase 2 / Phase 3	11	University Health Network, TorontoOTHER	1	Aug 12, 2025	clinicaltrials